AI Coming for Pharmacy Benefit Managers: Winners and Losers
Artificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
Pitfalls can derail a budget quickly. This guide shares practical strategies to identify, prevent, and recover from budgeting slips.
8,082 articlesArtificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
As markets shift in mid-2026, investors seek a practical starting point for stock exposure. The article lays out star...
A veteran investor argues that China’s full AI stack is underpriced as a major funding round and an upcoming Hong Kon...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
A veteran figure in AI, nicknamed the 'godfather ai,' argues big tech prioritizes short-term profits over the endgame...
Investors debate whether e.l.f. Beauty stock is cheap or fairly valued. This article breaks down growth, margins, and...
Grab is moving to pilot a new delivery robot in Singapore’s Punggol district by late 2026, aiming to relieve labor sh...
ECB board member Isabel Schnabel presses for a digital euro to counter stablecoin risks, signaling tighter regulation...
A team of researchers behind AI-driven biology raises a $50 million seed round to scale models that read, write, and ...
Inflation is squeezing wallets, but Synchrony’s credit numbers improving narrative suggests the everyday consumer is ...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...